The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global ...

A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share ...

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...

Cochlear isn’t selling hearing implants like it thought it could or should. It’s been a problem throughout its whole ...

Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET In this video Cochlear CEO Dig Howitt says its medical devices are largely exempt from tariffs. He also talks about the latest innovations and ...

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity. The post Down 43% this week, are Cochlear shares now the best bargain buy of the year?

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

The ASX 200 suffered its sharpest fall in over a month, down 1.18%, as a record one-day drop in Cochlear shares and CSL’s slide to multi-year lows hammered the healthcare sector. Cochlear cut its FY26 ...

Dig Howitt, CEO and President of Cochlear, shares the company's growth strategy in Asia. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered ...